In 2024, CBD (cannabidiol) continues to gain traction and generate buzz in various fields. A product derived from legal cannabis, it is sought after for its beneficial health effects without the psychoactive effects of THC. In this article, we provide an overview of the latest news and information about CBD in France in 2024.
CBD-infused culinary recipes for Christmas 2023
Even food lovers haven't escaped the cannabidiol craze. CBD-infused culinary preparations proliferated during the 2023 holiday season. CBD-based ingredients replaced some traditional seasonings at family meals. Of course, for children, it's possible to substitute other ingredients for CBD.
It is essential to carefully choose the CBD products used in your cooking recipes. To do this, prioritize well-known brands and products produced in a way that respects the environment and the consumer.
How to choose the right CBD products?
Here are some tips for choosing the best CBD products:
- Check the CBD concentration
- Choose products from organic farming
- Make sure the product does not contain more than 0.2% THC (the legal limit in France)
- Read reviews and testimonials from other customers
PAX: A unique collaboration with artist James Goldcrown
Iconic cannabis vaporizer brand PAX has teamed up with self-taughtLos Angeles-based artist James Goldcrown, known for his murals “Bleeding Hearts” and “Lovewall.” This limited-edition holiday collaboration, titled “Love: Hits Different,” uniquely blends his passion for art and cannabis.
PAX demonstrates once again its commitment to supporting visionary creators. Standing up against the prevailing gloom, this capsule showcases the iconic “Bleeding Hearts” motif in various formats: on lighters, grinders, and even cases for the brand's vaporizers.
James Goldcrown: An inspiring journey
Born in the UK and raised in Zimbabwe, James Goldcrown is an unconventional artist. He began as a documentary filmmaker before dedicating himself fully to painting. His international renown now allows him to work with prestigious brands such as PAX.
The use of medical cannabis: widespread adoption expected by 2024?
Several members of parliament, from both the majority and the opposition, are calling on the French government to stop postponing the widespread use of medical cannabis for patients with no other therapeutic options. This initiative follows an opinion piece published online and signed by these elected officials.
Medical cannabis has been in the experimental phase in France since January 2021, under certain strict conditions. The approved indications include neuropathic pain that is resistant to other treatments, severe drug-resistant epilepsy syndromes, and certain symptoms associated with advanced cancers.
What hopes are there for the legalization of cannabis for therapeutic use?
At present, it is difficult to predict what the French government's decision will be regarding the use of medical cannabis. However, many European countries, such as Germany, Italy, and Spain, have already taken this step, and the World Health Organization has officially recognized the therapeutic benefits of CBD. This could be a strong argument in favor of future legalization for French patients struggling with their health conditions.
Sources
- https://lecannabiste.com/recettes-simples-noel-au-cannabis/
- https://www.newsweed.fr/pax-lance-une-collection-de-noel-avec-james-goldcrown/
- https://www.lemoniteurdespharmacies.fr/actu/actualites/actus-medicaments/cannabis-medical-pourquoi-une-generalisation-est-elle-attendue-en-2024.html
Co-founder of CBD.fr
Julien Cordobes is the editor of CBD.fr. Born in 1978 in the Paris region, he first trained in e-commerce before turning to natural health approaches, a dual perspective that now structures his way of writing about cannabidiol: reading the scientific literature as it is, without hardening the conclusions, and presenting it in a language that everyone understands.
He discovered CBD at a time when the French market was developing faster than the information available to it. He acquired CBD.fr in 2022 and then took on editorial responsibility for the blog. Since then, he has published numerous articles covering the daily use of CBD, the interpretation of laboratory analyses, the evolution of the legal framework, and precautions for use.
